BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Genetown

  AvenCell Announces First Patient Dosed in a Phase IA Study with lead product candidate AVC-201

  AvenCell Therapeutics, Inc. today announced that it has dosed the first patient in a Phase IA study with AVC-201 for the treatment of relapsed/refractory Acute Myeloid Leukemia (AML) and other selected hematologic malignancies positive for CD123 (NCT05949125).

  February 6, 2024

   · 

  7 min read
• Pharm Country

  Rallybio Announces Portfolio Prioritization and Provides Corporate Update

  Rallybio Corporation announced the prioritization of its portfolio and a 45% workforce reduction to focus resources on its Phase 2-ready clinical stage programs, RLYB212 and RLYB116.

  February 6, 2024

   · 

  8 min read
• Deals

  Immunome to Acquire AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala Pharmaceuticals

  Immunome, Inc. today announced that it entered into a definitive asset purchase agreement with Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, to acquire AL102.

  February 6, 2024

   · 

  8 min read
• Business

  AVS Appoints Elizabeth Galle as Vice President of Clinical Affairs

  AVS, an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease with its PIVL™ therapy, announced the appointment of Elizabeth Galle as the company’s new Vice President of Clinical Affairs.

  February 6, 2024

   · 

  2 min read
• Business

  PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care

  PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care.

  February 6, 2024

   · 

  8 min read
• Business

  Parse Biosciences Partners with INTEGRA Biosciences for Automated Single Cell Workflows

  Parse Biosciences today announced it has entered into an agreement with INTEGRA Biosciences to integrate the Assist Plus with built-in Parse Evercode™ single cell protocols.

  February 6, 2024

   · 

  2 min read
• Biotech Bay

  Twist Bioscience Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications

  Twist Bioscience Corporation today launched the cfDNA Library Preparation Kit to enable liquid biopsy research.

  February 6, 2024

   · 

  6 min read
• Business

  Gallant Therapeutics Adds Animal Health Executive Aaron Schacht to Board of Directors

  Gallant Therapeutics today announced the addition of Aaron Schacht to its Board of Directors.

  February 6, 2024

   · 

  2 min read
• Biotech Beach

  Study Results: MD Revolution and Cardiac Solutions Achieve 50% Reduction in 30-Day Cardiovascular Readmissions Using RevUp Remote Care Management

  MD Revolution announced that its partner, Cardiac Solutions achieved a 50% reduction in hospital cardiovascular readmission rates by using RevUp Remote Patient Monitoring and Chronic Care Management as part of their program.

  February 6, 2024

   · 

  4 min read
• Deals

  Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 6, 2024

  Inozyme Pharma, Inc. today announced that it granted stock options to four new employees to purchase shares of the Company’s common stock.

  February 6, 2024

   · 

  1 min read